Enterprise Value
55.32M
Cash
416.6M
Avg Qtr Burn
-16.96M
Short % of Float
9.56%
Insider Ownership
13.64%
Institutional Own.
32.37%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|